<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/vtgn" ></link>
<id>urn:uuid:045d3e94-4be1-701e-2fc5-041011d706b8</id>
<updated>2026-06-09T06:23:58-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>VTGN: ANGELOV ANGEL S (O) Filed a Form 3, Becoming a Registered Insider at VISTAGEN THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6406730" ></link>
<id>urn:uuid:923cc6c4-201e-13ea-a710-36204e0f4390</id>
<updated>2026-05-19T16:51:49-04:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: PRINCE JOSHUA S (COO) Acquired (JB) 4,386 Shares of VISTAGEN THERAPEUTICS INC for $0.56 on 12/31</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6302589" ></link>
<id>urn:uuid:67b0d3dd-5ba7-79a3-ebc9-bc2e003fe09e</id>
<updated>2026-01-05T20:51:53-05:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: TRESSLER NICK B (CFO) Filed a Form 3, Becoming a Registered Insider at VISTAGEN THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6286543" ></link>
<id>urn:uuid:326bb5a2-190b-be77-ffa6-ce3bff323559</id>
<updated>2025-12-04T06:05:45-05:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: EDICK PAUL R (DIR) Filed a Form 3, Becoming a Registered Insider at VISTAGEN THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6271241" ></link>
<id>urn:uuid:deabe1d4-5eae-dc78-c69e-ec0eff7e8c71</id>
<updated>2025-11-04T16:33:34-05:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: PRINCE JOSHUA S (COO) Acquired (JB) 4,882 Shares of VISTAGEN THERAPEUTICS INC for $1.70 on 6/30</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6223546" ></link>
<id>urn:uuid:99efe2e2-4ed7-f975-ac5a-2901e7ef9501</id>
<updated>2025-07-01T17:51:38-04:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: ADLER REID G (LO) Acquired (JB) 7,541 Shares of VISTAGEN THERAPEUTICS INC for $1.70 on 6/30</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6223542" ></link>
<id>urn:uuid:c92de409-de4b-898a-af3d-cb4125c38a45</id>
<updated>2025-07-01T17:50:42-04:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: ANDERSON CYNTHIA LYNN (CFO) Acquired (JB) 6,617 Shares of VISTAGEN THERAPEUTICS INC for $1.70 on 6/30</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6223545" ></link>
<id>urn:uuid:6050d0f3-f1c1-0b10-5d0f-64349c9ee559</id>
<updated>2025-07-01T17:49:44-04:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: SINGH SHAWN (PR,CEO,DIR) Acquired (JB) 7,541 Shares of VISTAGEN THERAPEUTICS INC for $1.70 on 6/30</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6223535" ></link>
<id>urn:uuid:f141fdca-328f-ce5d-d817-303c40204633</id>
<updated>2025-07-01T17:48:28-04:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: COTE ELISSA S (O) Filed a Form 3, Becoming a Registered Insider at VISTAGEN THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6221247" ></link>
<id>urn:uuid:315f1925-ef52-12ec-8792-194609faa569</id>
<updated>2025-06-25T17:15:54-04:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
<entry>
<title>VTGN: PRINCE JOSHUA S (COO) Acquired (JB) 3,310 Shares of VISTAGEN THERAPEUTICS INC for $2.51 on 12/31</title>
<link href="http://www.insiderinsights.com/company/vtgn/vistagen-therapeutics-inc/id-6112495" ></link>
<id>urn:uuid:c72ba5a1-a945-3303-e640-46307df9cd67</id>
<updated>2025-01-13T17:40:58-05:00</updated>
<summary type="html" ><![CDATA[VISTAGEN THERAPEUTICS INC (VTGN). Recent Price: $0.54. Mkt Cap:21.5mm. 10D Vol: 614,010]]></summary>
</entry>
</feed>